European industry pins hopes on Commission to stop French premarket rule
This article was originally published in Clinica
The European medical device industry is cautiously optimistic that the European Commission will order the French government to drop its proposal for stricter requirements for high-risk medical devices than are necessary under European law.
You may also be interested in...
Women implanted with Bayer’s Essure birth-control device have significantly higher rates of pelvic pain, uterine bleeding and hypersensitivity compared to women who undergo tubal ligation, according to initial results from a government-mandated postmarket study. See what US FDA’s spokeswoman Alison Hunt said about it here.
Companies developing antibiotics to get financial and technical support from more than 20 firms contributing to new AMR Action Fund. Initiative is also pushing for reimbursement reform and other policies to support commercial marketing.
Joe Biden’s presidential campaign now has a plan to address supply chains and encourage US-based manufacturing of prescription drugs. That affirms the unlikely national prominence of the issue – and reduces the chances of meaningful legislation this year.